
Antimicrobial Resistance Multi-Partner Trust Fund
OverviewThe Antimicrobial Resistance Multi-Partner Trust Fund
The Antimicrobial Resistance Multi-Partner Trust Fund (MPTF) combats the threat of antimicrobial drug resistance through strategic collaboration, sustainable streams of capital, and Sustainable Development Goal-focused responses that support localized ‘One Health’ National Action Plans.
OverviewIn Focus
Status:
Latest reports:
- Antimicrobial Resistance Multi-Partner Trust Fund Consolidated Annual Progress Report 2022
- Antimicrobial Resistance Multi-Partner Trust Fund Consolidated Financial Report 2022
- Antimicrobial Resistance Multi-Partner Trust Fund Certified Financial Statement (Sources and Uses of Funds) 2022
Fund established:
OverviewKey financial figures





OverviewContributions
The work of the Antimicrobial Resistance Multi-Partner Trust Fund are possible thanks to the generous contributions by public and private sector partners
ContributorsMulti-stakeholder partnerships
The work of the Antimicrobial Resistance Multi-Partner Trust Fund is possible thanks to the efforts of . These resources are pooled and channelled to participating organizations to promote joint action and multi-stakeholder partnerships, making a difference on the ground.

OverviewPartner organizations receiving funding
